+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Drugs Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Semi-Solid Formulations, Solid Formulations), Scale of Operation (Clinical), End-use (Pharmaceutical Companies), Region, with Growth Forecasts, 2025-2030- Product Image
Topical Drugs Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Semi-Solid Formulations, Solid Formulations), Scale of Operation (Clinical), End-use (Pharmaceutical Companies), Region, with Growth Forecasts, 2025-2030- Product Image
New

Topical Drugs Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Semi-Solid Formulations, Solid Formulations), Scale of Operation (Clinical), End-use (Pharmaceutical Companies), Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 6085820
Description Jump to:
The Topical Drugs Contract Manufacturing Market was valued at USD 29.25 Billion in 2024, and is projected to reach USD 54.55 Billion by 2030, rising at a CAGR of 11.05%. Currently, the global market for contract manufacturing of topical drugs is currently experiencing significant growth, driven by evolving therapeutic needs, outsourcing trends, and advancements in technology. Moreover, with the increasing prevalence of dermatological conditions, coupled with a rising geriatric population and a preference for non-invasive drug delivery methods such as creams, gels, ointments, sprays, and transdermal patches has made outsourcing services like Contract Manufacturing Organizations (CMOs) essential for optimizing costs, ensuring regulatory compliance, and enhancing production capabilities. In addition, CMOs offer numerous advantages that support streamline operations, lower in-house manufacturing expenses, and speed up product commercialization, further contributing to market expansion. In addition, with the rising consumer demand for topical drugs, outsourcing has become a strategic priority, particularly for semi-solid and transdermal product lines that require specialized expertise and adaptable infrastructure.

Furthermore, cost dynamics play a crucial role in the growth of the market. Based on the pricing analysis, the North America provides high-quality manufacturing that complies with regulatory standards, while the Asia-Pacific’s countries like India, China, and South Korea offers more cost-effective production options with growing capabilities. Factors such as lower labor costs, supportive government policies, and a developing infrastructure complaint with Good Manufacturing Practices (GMP) are fueling the market in Asia-Pacific. Furthermore, technological innovations such as continuous manufacturing, nanoencapsulation, advanced homogenization, and 3D printing are improving formulation accuracy, bioavailability, and batch consistency. These advancements support the CMOs to meet complex product demands and meet rising consumer expectations for efficacy and customization.

Furthermore, pricing models are evolving with aligning financial results with performance. However, external factors like U.S. tariffs on imported active pharmaceutical ingredients (APIs) and excipients have created cost pressures in the supply chain, particularly impacting exporters. Despite these challenges, the market is expected to witness growth during the forecast period. Likewise, strategic initiatives and accelerating product launches drive the market. For instance, in July 2024, Arcutis Biotherapeutics, Inc. announced the release of ZORYVE cream 0.15% for the treatment of mild to moderate atopic dermatitis in both adults and children under 6 in the U.S. This new cream, which is applied once daily and contains no steroids, provides quick relief from symptoms and reduces itching, allowing for better long-term management of the condition. Such innovations are expected to further propel the market during the forecast period.

Topical Drugs Contract Manufacturing Market Report Highlights

  • The semi-solid formulations segment dominated the market, with a share of 65.54% in 2024. This growth is driven by the increasing prevalence of skin diseases, patient preferences for targeted therapies, the convenience of semi-solid formulations, and the demand for improved drug absorption, stability, and aesthetic appeal within both therapeutic and cosmetic sectors.
  • Based on the scale of operation, the commercial segment held the largest market share in 2024, attributed to the growing trend toward outsourcing, increased demand for dermatological and transdermal therapies, regulatory compliance, increased cost efficiency, and the rising complexity of formulations that require specialized manufacturing expertise.
  • The pharmaceutical companies segment held the largest market share in 2024 based on end-use. These companies leverage CMO services due to increasing demand for non-invasive therapies, treatments for chronic skin conditions, improved patient compliance, and opportunities within cosmetic dermatology and advanced transdermal drug delivery systems.
  • North America is expected to register a growth rate of 10.37% CAGR over the forecast period due to the rising number of contract manufacturing organizations(CMOs) in countries such as the U.S. and Canada. In addition, the availability of a skilled workforce and regulatory scenarios are expected to significantly contribute to the market's expansion in this region.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. Scale of Operation
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Topical Drugs Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Market Analysis Tools
3.5.1. Porter’s Five Force Analysis
3.5.2. PESTEL by SWOT Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Topical Drugs Contract Manufacturing Market: Product Type Estimates & Trend Analysis
4.1. Topical Drugs Contract Manufacturing Market, by Product Type: Segment Dashboard
4.2. Topical Drugs Contract Manufacturing Market, by Product Type: Movement Analysis
4.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, by Product Type, 2018-2030
4.4. Semi-Solid Formulations
4.4.1. Semi-Solid Formulations Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Creams
4.4.2.1. Creams Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.3. Ointments
4.4.3.1. Ointments Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.4. Gel
4.4.4.1. Gel Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Liquid Formulations
4.5.1. Liquid Formulations Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Solid Formulations
4.6.1. Solid Formulations Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Transdermal Products
4.7.1. Transdermal Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Topical Drugs Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis
5.1. Topical Drugs Contract Manufacturing Market, by Scale of Operation: Segment Dashboard
5.2. Topical Drugs Contract Manufacturing Market, by Scale of Operation: Movement Analysis
5.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, by Scale of Operation, 2018-2030
5.4. Clinical
5.4.1. Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Commercial
5.5.1. Commercial Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Topical Drugs Contract Manufacturing Market: End Use Estimates & Trend Analysis
6.1. Topical Drugs Contract Manufacturing Market, by End Use: Segment Dashboard
6.2. Topical Drugs Contract Manufacturing Market, by End Use: Movement Analysis
6.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, by End Use, 2018-2030
6.4. Pharmaceutical Companies
6.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Biopharmaceutical Companies
6.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Others
6.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Topical Drugs Contract Manufacturing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. North America Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.2. U.S
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Europe
7.5.1. Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.5. Thailand
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.7. Australia
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. MEA
7.8.1. MEA Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Share/Assessment Analysis, 2024
8.3. Company Profiles
8.3.1. MedPharm
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. DPT Laboratories Ltd
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Cambrex Corporation
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Kindeva Drug Delivery
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. AbbVie Contract Manufacturing
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. NextPharma
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Catalent Pharma Solutions
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Thermo Fisher Scientific
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Lonza Group
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. The Lubrizol Corporation
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. SGS S.A.
8.3.11.1. Company Overview
8.3.11.2. Financial Performance
8.3.11.3. Service Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Bora Pharmaceutical CDMO
8.3.12.1. Company Overview
8.3.12.2. Financial Performance
8.3.12.3. Service Benchmarking
8.3.12.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 4 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 5 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 6 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Region, 2018-2030 (USD Million)
Table 7 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 8 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 9 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 10 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 11 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 12 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 13 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 14 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 15 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 16 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 17 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 18 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 19 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 20 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 21 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 22 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 23 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 24 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 25 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 26 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 27 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 28 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 29 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 30 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 31 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 32 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 33 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 34 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 35 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 36 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 37 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 38 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 39 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 40 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 41 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 42 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 43 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 44 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 45 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 46 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 47 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 48 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 49 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 50 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 51 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 52 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 53 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 54 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 55 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 56 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 57 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 58 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 59 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 60 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 61 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 62 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 63 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 64 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 65 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 66 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 67 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 68 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 69 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 70 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 71 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 72 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 73 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 74 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 75 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 76 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 77 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 78 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 79 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 80 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 81 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 82 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 83 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 84 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 85 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 86 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 87 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 88 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 89 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 90 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 91 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 92 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
Table 93 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 94 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018-2030 (USD Million)
Table 95 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Topical Drugs Contract Manufacturing Market dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Topical Drugs Contract Manufacturing Market: Product Type outlook and key takeaways
Figure 20 Topical Drugs Contract Manufacturing Market: Product Type movement analysis
Figure 21 Semi-solid Formulations Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Creams Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Ointments Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Gel Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Liquid Formulations Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Solid Formulations Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Transdermal Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Topical Drugs Contract Manufacturing Market: Scale of Operation outlook and key takeaways
Figure 30 Topical Drugs Contract Manufacturing Market: Scale of Operation movement analysis
Figure 31 Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Commercial Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Topical Drugs Contract Manufacturing Market: End Use outlook and key takeaways
Figure 34 Topical Drugs Contract Manufacturing Market: End Use movement analysis
Figure 35 Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Biopharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Regional Marketplace: Key Takeaways
Figure 39 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Key country dynamics
Figure 41 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Key country dynamics
Figure 43 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Key country dynamics
Figure 45 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Key country dynamics
Figure 48 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Key country dynamics
Figure 50 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Key country dynamics
Figure 52 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Key country dynamics
Figure 54 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Key country dynamics
Figure 56 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Key country dynamics
Figure 60 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Key country dynamics
Figure 62 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Key country dynamics
Figure 65 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 Key country dynamics
Figure 69 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 70 Key country dynamics
Figure 71 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 Key country dynamics
Figure 73 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 77 Key country dynamics
Figure 78 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 81 MEA Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 86 Key country dynamics
Figure 87 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 88 Key country dynamics
Figure 89 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 90 Key company categorization
Figure 91 Service heat map analysis
Figure 92 Strategic framework

Companies Mentioned

The companies profiled in this Topical Drugs Contract Manufacturing market report include:
  • MedPharm
  • DPT Laboratories Ltd
  • Cambrex Corporation
  • Kindeva Drug Delivery
  • AbbVie Contract Manufacturing
  • NextPharma
  • Catalent Pharma Solutions
  • Thermo Fisher Scientific
  • Lonza Group
  • The Lubrizol Corporation
  • SGS S.A.
  • Bora Pharmaceutical CDMO

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedApril 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 29.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 54.55 Billion
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

North America Topical Drugs CDMO Market Size, Share & Trends Analysis Report by Product Type (Semi-Solid, Liquid), Service Type (Contract Development, Contract Manufacturing), Sponsors, Country, and Segment Forecasts, 2024-2030 - Product Image

North America Topical Drugs CDMO Market Size, Share & Trends Analysis Report by Product Type (Semi-Solid, Liquid), Service Type (Contract Development, Contract Manufacturing), Sponsors, Country, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • North America
From
Topical Drug Delivery Market - Global Forecast to 2030 - Product Image

Topical Drug Delivery Market - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Topical Drugs Market - Global Forecast to 2030 - Product Image

Topical Drugs Market - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Dexamethasone Sodium Phosphate Active Pharmaceutical Ingredients Market - Global Forecast to 2030 - Product Image

Dexamethasone Sodium Phosphate Active Pharmaceutical Ingredients Market - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.